IDEXX Laboratories Inc (IDXX)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$465.00

Buy

$480.00

arrow-up$0.52 (+0.11%)

Prices updated at 03 May 2025, 00:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
NASDAQ
arrow-up1.51%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Lawrence D. Kingsley
CEO
Mr. Jonathan J. Mazelsky
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
11,000
Head office
One IDEXX Drive
Westbrook
United States
04092
mobile
+1 207 556-0300
letter
john-ravis@idexx.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Brian P. Mckeon
Executive Vice President and Special Advisor
0.69m
Mr. Bruce L. Claflin
Independent Director
0.11m
Mr. Daniel M. Junius
Independent Director
0.12m
Ms. M. Anne Szostak
Independent Director
0.12m
Mr. Lawrence D. Kingsley
Non-Executive Chairman of the Board
0.17m
Dr. Sophie V. Vandebroek, PhD
Independent Director
0.09m
Mr. Stuart M. Essig, PhD
Independent Director
0.11m
Ms. Irene Chang Britt
Independent Director
0.11m
Mr. George J. Fennell
Executive Vice President, Global CAG Commercial
-
Mr. Jonathan J. Mazelsky
Director, President and Chief Executive Officer
1.12m
Dr. Martin Alexander Smith, PhD
Executive Vice President, Global Operations and Research and Development
0.58m
Ms. Sharon E. Underberg
Executive Vice President, General Counsel and Corporate Secretary
-
Mr. Sam A. Samad
Independent Director
0.10m
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
0.58m
Dr. Nimrata Khatra Hunt, PhD
Executive Vice President, Global Strategy and Commercial
0.58m
Mr. Michael P. Johnson
Senior Vice President and Chief Human Resources Officer
-
Dr. Michael G. Erickson, PhD
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
-
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
-
Mr. Andrew Emerson
Executive Vice President, Chief Financial Officer and Treasurer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc9,709,510
Vanguard Group Inc. ( Junked)9,703,237
BlackRock Inc8,472,562
State Street Corp3,637,560
BlackRock Fund Advisors3,587,497

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
27 Nov 2024-
27 Nov 2024-
06 Sep 2024-
06 Sep 2024-
06 Sep 2024-
06 Sep 2024-
05 Sep 2024-
06 Sep 2024-
05 Sep 2024-
01 Sep 2024-
01 Sep 2024-
01 Sep 2024-
01 Sep 2024-
01 Sep 2024-
01 Sep 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
05 Aug 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.